17 - 19 October 2019
Florence, Italy

Scientific Programme

Scientific Programme

The scientific programme will include the below planned symposia:

  • Immunotherapy of allergic diseases in children: when and how?
  • Asthma in children: role of endotypes and phenotypes in targeting the pharmacologic approach
  • Severe asthma: how to achieve the best adherence and control
  • Food allergy: new horizons towards a cure
  • Cow’s milk allergy: phenotypes and selection of special products for the management
  • Immunodeficiencies: lessons for the pediatric allergists and new advancements
  • Atopic dermatitis and biologicals: how is this changing the scenario?
  • Is anaphylaxis in children a rare disease?
  • Severity score for severe allergic reactions
  • Vaccines: from bench to bedside
  • How to improve adherence in pediatric allergic diseases: psycological intervention and new models
  • The cat or not the cat? How to best manage cat and pet allergy
  • eHealth for allergic diseases in children: facts and myths
  • Rhinitis: the big phenotypes dilemma: allergic, non-allergic, mixed?
  • Managing allergic rhinitis in children: between pharmacology and immunotherapy and beyond
  • How to best treat non-allergic rhinitis in teens
  • Molecular allergology at the forefront of early diagnosis and personalized treatment of allergic diseases in children
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel